Jeffrey G. Black - Aug 15, 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP & Chief Financial Officer
Signature
/s/Jeffrey G Black by Agnieszka Gallagher, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
Aug 15, 2024
Transactions value $
-$7,277
Form type
4
Date filed
8/19/2024, 05:30 PM
Previous filing
May 21, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Options Exercise $0 +13.2K +3.13% $0.00 433K Aug 15, 2024 Direct
transaction LAB Common Stock Tax liability -$7.28K -4.7K -1.08% $1.55 428K Aug 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Options Exercise $0 -13.2K -8.33% $0.00 145K Aug 15, 2024 Common Stock 13.2K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 15, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023.
F2 Each RSU represents the contingent right to receive one share of the Issuer's common stock.
F3 On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and 1/16th of the RSUs vested on August 15, 2024. The remaining unvested RSUs will be forfeited due to the resignation of the Reporting Person effective as of August 31, 2024.